---
title: "District-level HIV and TB vulnerability to climate hazards in South Africa: a composite index anal"
id: "medrxiv-4-district-level-hiv-and-tb-health-system-vulnerability-to-climate-and-weather"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-4-district-level-hiv-and-tb-health-system-vulnerability-to-climate-and-weather"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.21.26360993v1?rss=1"
published_at: "2026-08-26T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# District-level HIV and TB vulnerability to climate hazards in South Africa: a composite index anal
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-4-district-level-hiv-and-tb-health-system-vulnerability-to-climate-and-weather
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.21.26360993v1?rss=1)
- **Published At:** 2026-08-26T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study developed a district-level composite **HIV/TB Vulnerability Index** for South Africa that integrates indicators of disease burden (sensitivity), health system capacity, and socio-economic vulnerability using publicly available data. - A separate **Hazard Index** was created from international hazard datasets to represent exposure to extreme weather events (EWEs) including heat stress, floods, and heavy rainfall. - Indicators were drawn from national surveys, routine health information systems, and international hazard datasets, normalised with min–max scaling and aggregated with equal weighting; sensitivity analyses were performed to test robustness. - High vulnerability districts clustered in the Northern Cape, Eastern Cape and KwaZulu-Natal where high HIV/TB burden and socio-economic sensitivity coincided with limited health system adaptive capacity. - Low vulnerability districts were concentrated in Gauteng and Western Cape, reflecting stronger health system capacity and more favourable socio-economic conditions. - Hazard exposure showed a geographic split: western districts had higher **heat stress** while eastern districts faced greater **flood and heavy-rainfall hazards**. - When combined, districts with both high HIV/TB vulnerability and high hazard exposure clustered mainly along the east coast (examples: Ugu, uMkhanyakude, Harry Gwala, O.R. Tambo, Alfred Nzo), indicating compound susceptibility. - The authors interpret that convergence of high disease burden, constrained health system capacity, and socio-economic disadvantage drives district-level vulnerability to climate hazards and that geographically targeted adaptation is needed to prioritise continuity of HIV/TB services and health system resilience. - Data used in the study are publicly available at cited sources or available upon reasonable request; the study is a preprint and has not been peer reviewed. - Funding was declared from the National Institute for Health and Care Research (NIHR204828). Authors declared no competing interests and reported compliance with ethical guidelines.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=bZJsaL0KQ0jCKRPf3HHDrD8xkXl_czcbz7fprif4.RE-1787764495.690567-1.2.1.1-kFx1ziLALka2AakETsfdABOx3JfNEvaLsgPhhV8WH8.tphrbrdxXVESI0CFxfogk) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.21.26360993v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # District-level HIV and TB health system vulnerability to climate and weather hazards in South Africa: a composite index approach Erofili Grapsa, Marlies Craig, Nondumiso Mthiyane, Sammy Khagayi, Saeideh Babashahi, Collins Iwuji doi: https://doi.org/10.64898/2026.08.21.26360993 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Erofili Grapsa 1 Africa Health Research Institute; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Erofili%2BGrapsa%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Grapsa%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AErofili%2BGrapsa%2B) * For correspondence: erofili.grapsa@ahri.org Marlies Craig 1 Africa Health Research Institute; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Marlies%2BCraig%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Craig%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMarlies%2BCraig%2B) Nondumiso Mthiyane 1 Africa Health Research Institute; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nondumiso%2BMthiyane%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Mthiyane%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANondumiso%2BMthiyane%2B) Sammy Khagayi 1 Africa Health Research Institute; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sammy%2BKhagayi%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Khagayi%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASammy%2BKhagayi%2B) Saeideh Babashahi 2 Brighton and Sussex Medical School, University of Sussex * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Saeideh%2BBabashahi%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Babashahi%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASaeideh%2BBabashahi%2B) Collins Iwuji 1 Africa Health Research Institute; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Collins%2BIwuji%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Iwuji%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ACollins%2BIwuji%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.21.26360993v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1286688/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.21.26360993v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1286688/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.21.26360993v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1286688/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.08.21.26360993v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1286688/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.21.26360993v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1286688/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.21.26360993v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1286688/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background Climate change and extreme weather events (EWEs) threaten health systems, disrupt continuity of HIV and TB services, amplify communicable disease burdens, and exacerbate health inequities in South Africa. Yet few empirical studies have quantified district-level vulnerability, where HIV and TB service delivery and climate adaptation are operationalised. Methods We developed a district-level composite HIV/TB Vulnerability Index, integrating indicators of HIV & tuberculosis burden (sensitivity), health system capacity, and socio-economic vulnerability. We also developed a Hazard Index which when combined with the HIV/TB vulnerability Index, identifies districts where underlying vulnerability coincides with higher likelihood of EWEs. Indicators were drawn from national surveys, routine health information systems, and international hazard datasets, normalised using a min-max scaling, and aggregated with equal weighting. Sensitivity analysis were conducted to assess the robustness of the composite indices. Findings The most vulnerable districts were located in the Northern Cape, Eastern Cape and KwaZulu Natal provinces where high HIV/TB burden and socio-economic sensitivity coincided with limited health system adaptive capacity. In contrast, the least vulnerable districts, were concentrated in Gauteng and Western Cape, reflecting stronger health system capacity and more favourable socio-economic conditions. Hazard exposure exhibited a clear spatial division with western districts experiencing greater heat stress and eastern districts facing higher flood and heavy-rainfall hazards. When hazard exposure was combined with the HIV/TB vulnerability Index, districts with both high vulnerability and hazard scores clustered predominantly along the east coast (Ugu, uMkhanyakude, and Harry Gwala in KwaZulu-Natal, and O.R. Tambo and Alfred Nzo in the Eastern Cape). Interpretation South Africa's district-level vulnerability to climate and weather hazards is driven by the convergence of high HIV/TB burden, constrained health system capacity, and socio-economic disadvantage. Where this vulnerability intersects with increased hazard risk, it creates a compound susceptibility that needs attention. Our findings provide evidence for geographically targeted adaptation, prioritising continuity of HIV/TB services, health system resilience, and hazard-specific preparedness. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced in the present study are publicly available at cited sources or available upon reasonable request to the authors. ## Funder Information Declared National Institute for Health and Care Research, NIHR204828 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.21.26360993v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.24.26361275v1 "Initial Staging 18F-FDG PET/CT for Coronary Artery Calcium Scoring to Assess Cardiovascular Risk in Women with Breast Cancer")[Next ](https://www.medrxiv.org/content/10.64898/2026.08.20.26360938v1 "A Two-Stage Multimodal Contrastive Framework for PET-Based Prediction of Obstructive Coronary Artery Disease") Posted August 26, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.21.26360993v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/26/2026.08.21.26360993.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.21.26360993v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.08.21.26360993v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/26/2026.08.21.26360993.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) District-level HIV and TB health system vulnerability to climate and weather hazards in South Africa: a composite index approach Erofili Grapsa, Marlies Craig, Nondumiso Mthiyane, Sammy Khagayi, Saeideh Babashahi, Collins Iwuji medRxiv 2026.08.21.26360993; doi: https://doi.org/10.64898/2026.08.21.26360993 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.21.26360993v1%26text%3DDistrict-level%2520HIV%2520and%2520TB%2520health%2520system%2520vulnerability%2520to%2520climate%2520and%2520weather%2520hazards%2520in%2520South%2520Africa%253A%2520a%2520composite%2520index%2520approach "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.21.26360993v1%26t%3DDistrict-level%2520HIV%2520and%2520TB%2520health%2520system%2520vulnerability%2520to%2520climate%2520and%2520weather%2520hazards%2520in%2520South%2520Africa%253A%2520a%2520composite%2520index%2520approach "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.21.26360993v1%26title%3DDistrict-level%2520HIV%2520and%2520TB%2520health%2520system%2520vulnerability%2520to%2520climate%2520and%2520weather%2520hazards%2520in%2520South%2520Africa%253A%2520a%2520composite%2520index%2520approach%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.21.26360993v1%26title%3DDistrict-level%2520HIV%2520and%2520TB%2520health%2520system%2520vulnerability%2520to%2520climate%2520and%2520weather%2520hazards%2520in%2520South%2520Africa%253A%2520a%2520composite%2520index%2520approach "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.21.26360993) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.21.26360993v1&count=horizontal&via=&text=District-level%20HIV%20and%20TB%20health%20system%20vulnerability%20to%20climate%20and%20weather%20hazards%20in%20South%20Africa%3A%20a%20composite%20index%20approach&counturl=www.medrxiv.org/content/10.64898/2026.08.21.26360993v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (612) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (892) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (325) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4751) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (473) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (406) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (639) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1609) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15789) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1193) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6960) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (725) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1050) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4957) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1421) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1730) * [Hematology](https://www.medrxiv.org/collection/hematology) (577) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1327) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16226) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1157) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (661) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (150) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (717) * [Neurology](https://www.medrxiv.org/collection/neurology) (7155) * [Nursing](https://www.medrxiv.org/collection/nursing) (360) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1071) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1223) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (998) * [Oncology](https://www.medrxiv.org/collection/oncology) (3561) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1031) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (390) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (444) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (464) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (702) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1769) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (730) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (758) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5809) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9657) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2370) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1425) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1236) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (631) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (762) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (571) * [Surgery](https://www.medrxiv.org/collection/surgery) (760) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (106) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (301) * [Urology](https://www.medrxiv.org/collection/urology) (285) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been tr
## Related Clinical Research

- [Urine-based Mtb antigen detection for childhood TB using an ultrasensitive ECL immunoassay](https://medichelpline.com/clinical-feed/medrxiv-16-the-accuracy-of-urine-based-mycobacterial-antigens-to-detect-childhood.md)
- [Determinants of Favorable MDR-TB Treatment Outcomes in Zambia, 2018–2022](https://medichelpline.com/clinical-feed/plos-one-16-determinants-of-favorable-treatment-outcomes-in-multidrug-resistant.md)
- [Predictors of Healthcare Costs for Commercially Insured Adults with Tuberculosis in the US (2013–2](https://medichelpline.com/clinical-feed/medrxiv-0-predictors-of-healthcare-costs-among-commercially-insured-persons-with.md)
- [COVID-19 and Reactivation of Epstein-Barr, Herpes, and Anelloviridae: Study Findings](https://medichelpline.com/clinical-feed/medical-news-today-0-covid-19-may-reactivate-epstein-barr-herpes-viruses-what-this-means.md)
- [FDA approves Moderna’s mRNA flu vaccine mFLUSIVA for adults 50+: what clinicians should know](https://medichelpline.com/clinical-feed/medical-news-today-0-moderna-s-mrna-flu-vaccine-approved-by-fda-when-is-it-available.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.